Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Blood Cancer Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Polymerase Chain Reaction Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Blood Cancer Molecular Diagnostics include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Agilent, Liferiver, Gpmedical and Zeesan, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Blood Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Cancer Molecular Diagnostics. This report contains market size and forecasts of Blood Cancer Molecular Diagnostics in global, including the following market information:
Global Blood Cancer Molecular Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blood Cancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blood Cancer Molecular Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Blood Cancer Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
Polymerase Chain Reaction
Molecular Hybridization
Biochip
Others
Global Blood Cancer Molecular Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Blood Cancer Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Hospital
Third-Party Testing Agency
Others
Global Blood Cancer Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Blood Cancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood Cancer Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Blood Cancer Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Agilent
Liferiver
Gpmedical
Zeesan
Berry Oncology
Annoroad
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blood Cancer Molecular Diagnostics, market overview.
Chapter 2: Global Blood Cancer Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Blood Cancer Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blood Cancer Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Blood Cancer Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blood Cancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blood Cancer Molecular Diagnostics Overall Market Size
2.1 Global Blood Cancer Molecular Diagnostics Market Size: 2022 VS 2029
2.2 Global Blood Cancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Blood Cancer Molecular Diagnostics Players in Global Market
3.2 Top Global Blood Cancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Blood Cancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Blood Cancer Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Blood Cancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Blood Cancer Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Blood Cancer Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Blood Cancer Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Blood Cancer Molecular Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Polymerase Chain Reaction
4.1.3 Molecular Hybridization
4.1.4 Biochip
4.1.5 Others
4.2 By Type - Global Blood Cancer Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Blood Cancer Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Blood Cancer Molecular Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Blood Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Blood Cancer Molecular Diagnostics Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Third-Party Testing Agency
5.1.4 Others
5.2 By Application - Global Blood Cancer Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Blood Cancer Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Blood Cancer Molecular Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Blood Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Blood Cancer Molecular Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Blood Cancer Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Blood Cancer Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Blood Cancer Molecular Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Blood Cancer Molecular Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Blood Cancer Molecular Diagnostics Revenue, 2018-2029
6.3.2 US Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.3.3 Canada Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.3.4 Mexico Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Blood Cancer Molecular Diagnostics Revenue, 2018-2029
6.4.2 Germany Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.4.3 France Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.4.4 U.K. Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.4.5 Italy Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.4.6 Russia Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.4.8 Benelux Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Blood Cancer Molecular Diagnostics Revenue, 2018-2029
6.5.2 China Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.5.3 Japan Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.5.4 South Korea Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.5.6 India Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Blood Cancer Molecular Diagnostics Revenue, 2018-2029
6.6.2 Brazil Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.6.3 Argentina Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Blood Cancer Molecular Diagnostics Revenue, 2018-2029
6.7.2 Turkey Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.7.3 Israel Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Blood Cancer Molecular Diagnostics Market Size, 2018-2029
6.7.5 UAE Blood Cancer Molecular Diagnostics Market Size, 2018-2029
7 Blood Cancer Molecular Diagnostics Companies Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Company Summary
7.1.2 Roche Diagnostics Business Overview
7.1.3 Roche Diagnostics Blood Cancer Molecular Diagnostics Major Product Offerings
7.1.4 Roche Diagnostics Blood Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Roche Diagnostics Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Blood Cancer Molecular Diagnostics Major Product Offerings
7.2.4 Abbott Blood Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 Thermo Fisher
7.3.1 Thermo Fisher Company Summary
7.3.2 Thermo Fisher Business Overview
7.3.3 Thermo Fisher Blood Cancer Molecular Diagnostics Major Product Offerings
7.3.4 Thermo Fisher Blood Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Thermo Fisher Key News & Latest Developments
7.4 Qiagen
7.4.1 Qiagen Company Summary
7.4.2 Qiagen Business Overview
7.4.3 Qiagen Blood Cancer Molecular Diagnostics Major Product Offerings
7.4.4 Qiagen Blood Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Qiagen Key News & Latest Developments
7.5 Illumina
7.5.1 Illumina Company Summary
7.5.2 Illumina Business Overview
7.5.3 Illumina Blood Cancer Molecular Diagnostics Major Product Offerings
7.5.4 Illumina Blood Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Illumina Key News & Latest Developments
7.6 Agilent
7.6.1 Agilent Company Summary
7.6.2 Agilent Business Overview
7.6.3 Agilent Blood Cancer Molecular Diagnostics Major Product Offerings
7.6.4 Agilent Blood Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Agilent Key News & Latest Developments
7.7 Liferiver
7.7.1 Liferiver Company Summary
7.7.2 Liferiver Business Overview
7.7.3 Liferiver Blood Cancer Molecular Diagnostics Major Product Offerings
7.7.4 Liferiver Blood Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Liferiver Key News & Latest Developments
7.8 Gpmedical
7.8.1 Gpmedical Company Summary
7.8.2 Gpmedical Business Overview
7.8.3 Gpmedical Blood Cancer Molecular Diagnostics Major Product Offerings
7.8.4 Gpmedical Blood Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Gpmedical Key News & Latest Developments
7.9 Zeesan
7.9.1 Zeesan Company Summary
7.9.2 Zeesan Business Overview
7.9.3 Zeesan Blood Cancer Molecular Diagnostics Major Product Offerings
7.9.4 Zeesan Blood Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Zeesan Key News & Latest Developments
7.10 Berry Oncology
7.10.1 Berry Oncology Company Summary
7.10.2 Berry Oncology Business Overview
7.10.3 Berry Oncology Blood Cancer Molecular Diagnostics Major Product Offerings
7.10.4 Berry Oncology Blood Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Berry Oncology Key News & Latest Developments
7.11 Annoroad
7.11.1 Annoroad Company Summary
7.11.2 Annoroad Business Overview
7.11.3 Annoroad Blood Cancer Molecular Diagnostics Major Product Offerings
7.11.4 Annoroad Blood Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Annoroad Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
